Beryl Drugs Market Cap

Beryl Drugs has a market cap or net worth of 103.21 million as of March 10, 2026. Its market cap has decreased by -38.63% in one year.

Market Cap

103.21M

Enterprise Value

145.55M

Revenue

176.65M

Ranking

n/a

PE Ratio

731.98

Stock Price

20.35

Market Cap Chart

Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 103.21M, an increase of 2,693.72%. That is a compound annual growth rate of 17.41%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	94.44M	-20.43%
Dec 31, 2025	118.68M	-35.27%
Dec 31, 2024	183.34M	63.50%
Dec 29, 2023	112.14M	70.08%
Dec 30, 2022	65.93M	7.26%
Dec 31, 2021	61.47M	54.00%
Dec 31, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 26, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Colinz Laboratories	105.42M
Shamrock Industrial Company	110.51M
Unjha Formulations	90.95M
Emmessar Biotech & Nutrition	123.90M
Cian Healthcare	125.23M
Norris Medicines	130.01M
Vivanza Biosciences	78.80M
Desh Rakshak Aushdhalaya	131.97M

Market Cap Rankings